Tokunaga T
Kekkaku. 1989 Feb;64(2):121-33.
An introductory overview on the present state and future prospect of the immunology of tuberculosis is presented with the following six chapters. 1. Contribution of tuberculosis immunologists to the modern immunology. When one reminds Koch's phenomenon, Freund's adjuvant, and the findings or new ideas of, for instance, cell-mediated transfer of tuberculin allergy, test of MIF which was first described as "lymphokines", effector macrophages activated with immune lymphocytes against mycobacterial infection, MHC-restriction for presenting tuberculin-antigen from macrophages to T cells, everyone may agree with saying that the tuberculosis immunology contributed greatly to the opening and development of modern immunology. 2. Central dogma of tuberculosis immunology. Tuberculosis immunology possesses a central dogma : infection of tubercle bacilli----phagocytosis----antigen presentation----expansion of specific T cell clone----production of lymphokines----macrophage activation----killing of the bacilli. Recent knowledges from modern immunology have clarified many things in or around this immunological process. However, there remain many important questions. In the following chapters and subtitles, what have been clarified and what are still unsolved will be described. 3. Induction of tuberculosis immunity. (1) Mechanisms of phagocytosis with macrophages, and natural resistance. (2) Antigen presentation and sensitized T cells. 4. Expression of tuberculosis immunity. (1) Lymphokines. (2) Activation of macrophages. (3) Immune suppression. 5. Special characters of tubercle bacilli in relation to the host response. Biochemistry of cellular components of tubercle bacilli and their biological activities have been reported by many investigators already in this journal. Therefore, the following items only are discussed here. (1) Mycobacterial proteins produced by gene-technology. (2) Adjuvant active derivatives of MDP. (3) DNA from BCG and its biological activities. (4) Difference of immunity induced by viable and dead bacilli. About (4), possible mechanisms to explain the difference are discussed, with emphasis of both MPB70 protein as an antigenic metabolite released from viable bacilli and the heat-shock mycobacterial proteins. 6. Unsolved problems in tuberculosis immunology. (1) Mechanisms of endogenous reactivation. (2) Development of new vaccine. (3) Others. In addition to the practical problems on tuberculin diagnosis and BCG vaccination, problems to be solved in and around the central dogma are discussed. Some examples of these problems are illustrated in Fig.7 in English.
以下六章对结核病免疫学的现状和未来前景进行了介绍性概述。1. 结核病免疫学家对现代免疫学的贡献。当人们提及科赫现象、弗氏佐剂,以及诸如结核菌素过敏的细胞介导转移、最初被描述为“淋巴细胞因子”的巨噬细胞移动抑制因子检测、免疫淋巴细胞激活的效应巨噬细胞抵抗分枝杆菌感染、巨噬细胞向T细胞呈递结核菌素抗原的MHC限制等发现或新观点时,每个人可能都会认同结核病免疫学对现代免疫学的开创和发展做出了巨大贡献。2. 结核病免疫学的中心法则。结核病免疫学有一个中心法则:结核杆菌感染——吞噬作用——抗原呈递——特异性T细胞克隆扩增——淋巴细胞因子产生——巨噬细胞激活——杀灭杆菌。现代免疫学的最新知识已经阐明了这个免疫过程中或其周围的许多情况。然而,仍然存在许多重要问题。在接下来的章节和小标题中,将描述已经阐明的内容和仍未解决的问题。3. 结核病免疫的诱导。(1) 巨噬细胞的吞噬机制和天然抵抗力。(2) 抗原呈递和致敏T细胞。4. 结核病免疫的表达。(1) 淋巴细胞因子。(2)巨噬细胞的激活。(3) 免疫抑制。5. 结核杆菌与宿主反应相关的特殊特性。许多研究者已经在本期刊上报道了结核杆菌细胞成分的生物化学及其生物学活性。因此,这里仅讨论以下内容。(1) 基因技术产生的分枝杆菌蛋白。(2) 胞壁酰二肽的佐剂活性衍生物。(3) 卡介苗的DNA及其生物学活性。(4)活杆菌和死杆菌诱导的免疫差异。关于(4),讨论了解释这种差异的可能机制,重点是作为活杆菌释放的抗原代谢产物的MPB70蛋白和热休克分枝杆菌蛋白。6. 结核病免疫学中未解决的问题。(1) 内源性再激活的机制。(2) 新疫苗的研发。(3) 其他问题。除了结核菌素诊断和卡介苗接种的实际问题外,还讨论了中心法则中及周围有待解决的问题。这些问题的一些例子在英文图7中进行了说明。